COMBINATIONS COMPRISING (A) 4-3,5-BIS-(2-HYDROXYPHENYL)-1,2,4-TRIAZOL -1-YLBENZOIC ACID AND (B) AN INTERFERON AND/OR A NUCLEOSIDE ANTI-METABOLIT AND USE THEREOF FOR THE PREPARATION OF MEDICAMENTS FOR TREATING CHRONIC HEPATITIS C

摘要

The invention relates to the use of 4-[3,5-Bis-(2-hydroxyphenyl)-[1,2,4]-triazol-1-yl]benzoic acid (hereinafter referred to as 'Compound I') for the manufacture of pharmaceutical compositions for the treatment of liver diseases in humans in which iron plays a role in pathogenesis, including viral diseases, such as chronic hepatitis C, optionally in conjunction with antiviral agents and for the treatment of non viral diseases, such as non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.